{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T14:40:09Z","timestamp":1752072009055,"version":"3.41.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,9]]},"DOI":"10.7759\/cureus.87604","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T14:09:01Z","timestamp":1752070141000},"source":"Crossref","is-referenced-by-count":0,"title":["Cutaneous Manifestation of a Rare Haematological Malignancy: A Case Report of the Presentation, Diagnosis, and Management of Blastic Plasmacytoid Dendritic Cell Neoplasm"],"prefix":"10.7759","author":[{"given":"Syeda Liaba","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyal Elahi","family":"Chatha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.7026","article-title":"Blastic plasmacytoid dendritic cell neoplasm","volume":"21","author":"Jain A","year":"2023","unstructured":"Jain A, Sweet K. Blastic plasmacytoid dendritic cell neoplasm. J Natl Compr Canc Netw. 2023, 21:515-21. 10.6004\/jnccn.2023.7026","journal-title":"J Natl Compr Canc Netw"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1139","article-title":"Plasmacytoid dendritic cell biology and its\u00a0role in immune-mediated diseases","volume":"9","author":"Ye Y","year":"2020","unstructured":"Ye Y, Gaugler B, Mohty M, Malard F. Plasmacytoid dendritic cell biology and its\u00a0role in immune-mediated diseases. Clin Transl Immunology. 2020, 9:e1139. 10.1002\/cti2.1139","journal-title":"Clin Transl Immunology"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.34345","article-title":"Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a promising future in the era of targeted therapeutics","volume":"128","author":"Adimora IJ","year":"2022","unstructured":"Adimora IJ, Wilson NR, Pemmaraju N. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a promising future in the era of targeted therapeutics. Cancer. 2022, 128:3019-26.","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.072645","article-title":"Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study","volume":"98","author":"Pagano L","year":"2013","unstructured":"Pagano L, Valentini CG, Pulsoni A, et al.. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica. 2013, 98:239-46. 10.3324\/haematol.2012.072645","journal-title":"Haematologica"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-448613","article-title":"Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation","volume":"121","author":"Roos-Weil D","year":"2013","unstructured":"Roos-Weil D, Dietrich S, Boumendil A, et al.. Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood. 2013, 121:440-6. 10.1182\/blood-2012-08-448613","journal-title":"Blood"},{"key":"ref6","unstructured":"Allogeneic stem cell transplant. Bone marrow transplant. (2025). Accessed. February 14, 2025: https:\/\/www.mayoclinic.org\/tests-procedures\/allogeneic-stem-cell-transplant\/pyc-20384863."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7101","article-title":"Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy","volume":"7","author":"Mart\u00edn-Mart\u00edn L","year":"2016","unstructured":"Mart\u00edn-Mart\u00edn L, Almeida J, Pomares H, et al.. Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy. Oncotarget. 2016, 7:10174-81. 10.18632\/oncotarget.7101","journal-title":"Oncotarget"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111708","article-title":"Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management","volume":"139","author":"Rawat PS","year":"2021","unstructured":"Rawat PS, Jaiswal A, Khurana A, Bhatti JS, Navik U. Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management. Biomed Pharmacother. 2021, 139:111708. 10.1016\/j.biopha.2021.111708","journal-title":"Biomed Pharmacother"},{"key":"ref9","article-title":"Blastic plasmacytoid dendritic cell neoplasm: a review of diagnosis, pathology, and therapy","volume":"S8","author":"Shapiro R","year":"2015","unstructured":"Shapiro R, Sangle N, Keeney M, Chin-Yee IH, Hsia CC, Lam S. Blastic plasmacytoid dendritic cell neoplasm: a review of diagnosis, pathology, and therapy. J Cell Sci Ther. 2015, S8:008.","journal-title":"J Cell Sci Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber DA","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et al.. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016, 127:2391-405. 10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050595","article-title":"Blastic plasmacytoid dendritic cell neoplasm: state of the art and prospects","volume":"11","author":"Sapienza MR","year":"2019","unstructured":"Sapienza MR, Pileri A, Derenzini E, et al.. Blastic plasmacytoid dendritic cell neoplasm: state of the art and prospects. Cancers (Basel). 2019, 11:595. 10.3390\/cancers11050595","journal-title":"Cancers (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.5.1556","article-title":"Clinical and biologic features of CD4(+)CD56(+) malignancies","volume":"99","author":"Feuillard J","year":"2002","unstructured":"Feuillard J, Jacob MC, Valensi F, et al.. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood. 2002, 99:1556-63. 10.1182\/blood.v99.5.1556","journal-title":"Blood"},{"key":"ref13","unstructured":"Blastic plasmacytoid dendritic cell neoplasm. Leukemia and Lymphoma Society. (2025). Accessed. February 14, 2025: https:\/\/www.lls.org\/leukemia\/blastic-plasmacytoid-dendritic-cell-neoplasm."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_235_18","article-title":"Blastic plasmacytoid dendritic cell neoplasm: case report and literature overview","volume":"65","author":"Kolerova A","year":"2020","unstructured":"Kolerova A, Sergeeva I, Krinitsyna J, Pronkina N, Sizikova S, Filimonov P, Kryuchkova I. Blastic plasmacytoid dendritic cell neoplasm: case report and literature overview. Indian J Dermatol. 2020, 65:217-21. 10.4103\/ijd.IJD_235_18","journal-title":"Indian J Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-021-02860-z","article-title":"A misdiagnosed case of blastic plasmacytoid dendritic cell neoplasm experiencing multiple recurrences who\u00a0underwent allogeneic stem cell transplantation: a case report","volume":"15","author":"Salemi F","year":"2021","unstructured":"Salemi F, Mortazavizadeh SM, Mirmoeeni S, Azari Jafari A, Kosari F, Naghibi Irvani SS. A misdiagnosed case of blastic plasmacytoid dendritic cell neoplasm experiencing multiple recurrences who\u00a0underwent allogeneic stem cell transplantation: a case report. J Med Case Rep. 2021, 15:292. 10.1186\/s13256-021-02860-z","journal-title":"J Med Case Rep"},{"key":"ref16","article-title":"Clinical characterization of leukemia cutis presentation","volume":"104","author":"Haidari W","year":"2019","unstructured":"Haidari W, Strowd LC. Clinical characterization of leukemia cutis presentation. Cutis. 2019, 104:326-30;E3.","journal-title":"Cutis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-113801","article-title":"The presence of defective Epstein-Barr Virus (EBV) infection in patients with EBV-associated hematological malignancy","volume":"132","author":"Okuno Y","year":"2018","unstructured":"Okuno Y, Murata T, Sato Y, et al.. The presence of defective Epstein-Barr Virus (EBV) infection in patients with EBV-associated hematological malignancy. Blood. 2018, 132:1562. 10.1182\/blood-2018-99-113801","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000647","article-title":"How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?","volume":"3","author":"Garnache-Ottou F","year":"2019","unstructured":"Garnache-Ottou F, Vidal C, Biichl\u00e9 S, et al.. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?. Blood Adv. 2019, 3:4238-51. 10.1182\/bloodadvances.2019000647","journal-title":"Blood Adv"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001144","article-title":"Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark","volume":"134","author":"Taylor J","year":"2019","unstructured":"Taylor J, Haddadin M, Upadhyay VA, et al.. Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark. Blood. 2019, 134:678-87. 10.1182\/blood.2019001144","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006645","article-title":"Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD","volume":"6","author":"Pemmaraju N","year":"2022","unstructured":"Pemmaraju N, Wilson NR, Garcia-Manero G, et al.. Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD. Blood Adv. 2022, 6:3027-35. 10.1182\/bloodadvances.2021006645","journal-title":"Blood Adv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/330683-cutaneous-manifestation-of-a-rare-haematological-malignancy-a-case-report-of-the-presentation-diagnosis-and-management-of-blastic-plasmacytoid-dendritic-cell-neoplasm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T14:09:03Z","timestamp":1752070143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/330683-cutaneous-manifestation-of-a-rare-haematological-malignancy-a-case-report-of-the-presentation-diagnosis-and-management-of-blastic-plasmacytoid-dendritic-cell-neoplasm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.87604","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,9]]}}}